CVS vs PRLB · P/E 16, rev $402.07B vs P/E 75, $1.89B cap
CVS Health Corp (CVS) versus Proto Labs Inc (PRLB) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Proto Labs Inc (PRLB) is a metal fabrication company listed on NYSE.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
PRLB does not have a complete income-statement cache yet.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. PRLB currently screens at market cap $1.89B and trailing P/E 75.1.
Not investment advice. Open the CVS and PRLB stock pages for the full models.
Not investment advice.